MALAYSIA WELCOMES FIRST MEDICAL TOURISM FAMILIARISATION TRIP FOR HEALTHCARE PROFESSIONALS FROM UZBEKISTAN AND KAZAKHSTAN

KUALA LUMPUR, Aug 6 (Bernama) — As demand for Malaysia’s healthcare services continues to grow across Central Asia, Malaysia is welcoming senior healthcare professionals from Uzbekistan and Kazakhstan for its first Medical Tourism Familiarisation Trip organised by Malaysia Healthcare Travel Council (MHTC) and Tourism Malaysia (TM), designed to deepen professional collaboration and expand referral opportunities between the regions. the initiative reflects the growing demand for Malaysian healthcare services across the region and aims to foster knowledge exchange and long-term partnerships between medical institutions in Malaysia and Central Asia.

From 3 to 10 August 2026, the programme brings together 16 distinguished healthcare professionals, including practicing physicians, professors and senior medical specialists from Uzbekistan and Kazakhstan, for an immersive study visit throughout the programme. Participants will gain first-hand insight into Malaysia’s internationally recognised healthcare ecosystem and integrated approach to healthcare travel.

During the week-long programme, the delegation will visit four of Malaysia’s leading private healthcare institutions including Gleneagles Hospital Kuala Lumpur, Pantai Hospital Kuala Lumpur, Prince Court Medical Centre, and Sunway Medical Centre. Participants will meet with hospital management teams, doctors and specialists to discuss clinical excellence, healthcare quality standards, international patient management and the practical aspects of delivering seamless care to international patients.

The initiative comes at a time of growing interest in Malaysia’s healthcare sector across Central Asia. In 2025, healthcare travel revenue from Kazakhstan increased by 29.4%, rising from approximately USD 400,000 to USD 520,000, while Uzbekistan recorded a 30.8% increase, growing from around USD 305,000 to USD 400,000. The consistent growth in both markets highlights the region’s rising importance as a source of international patients and reflects increasing confidence in Malaysia’s high-quality, internationally accredited healthcare services. Malaysia currently attracts around 1.84 million international patients each year, resulting in over USD 770 million in healthcare travel revenue annually. The country’s healthcare system includes over 90 partner hospitals and providers, delivering internationally recognized expertise in various fields such as cardiology, oncology, orthopaedics, fertility treatments, and dentistry. 

Dato’ Suriaghandi said the familiarisation programme reflects MHTC’s commitment to building stronger professional relationships with healthcare communities in emerging markets while creating greater awareness of Malaysia’s healthcare capabilities among key medical decision-makers. He noted that healthcare professionals play an important role in influencing patients’ healthcare choices, making long-term engagement essential in strengthening Malaysia’s position as a preferred medical tourism destination.

“Trust is at the heart of every healthcare journey. By welcoming healthcare professionals to experience Malaysia’s healthcare ecosystem first-hand, we hope to foster meaningful relationships built on confidence, knowledge and shared commitment to patient care. That is the essence of Healing Meets Hospitality where clinical excellence is complemented by genuine compassion, creating a healthcare experience that patients can trust.” Dato’ Suriaghandi Suppiah, CEO of MHTC.

Beyond the professional visits, the delegation will also experience Malaysia’s rich cultural heritage through visits to Kuala Lumpur, the UNESCO World Heritage city of Melaka and Putrajaya. By combining world-class healthcare with renowned hospitality, modern infrastructure and diverse tourism experiences, Malaysia offers international patients a comprehensive healthcare travel journey that extends well beyond medical treatment.

Photo can be found in this link:
https://drive.google.com/drive/folders/15D6oZDyMxbpR4tLuADIe64hRM-LTX3V2?usp=drive_link

SOURCE: Malaysia Healthcare Travel Council (MHTC)

FOR MORE INFORMATION, PLEASE CONTACT:
Name: Muhammad Rasydan Ma’at
Head of Unit
PR and Media
Communications
Tel: +603 8776 6168
Email: rasydan.m@mhtc.org.my
 
Name: Mohamad Shahizam Fauzi                                                       
Head, Communications
Tel: +603 8776 6168                                                                                     
Email: shahizam.f@mhtc.org.my 

–BERNAMA

KFSHRC ACHIEVES WORLD’S FIRST SINGLE-PORT ROBOTIC LIVER TRANSPLANT

KUALA LUMPUR, July 22 (Bernama) — King Faisal Specialist Hospital and Research Centre (KFSHRC) has performed the world’s first liver transplant using a single-port robotic system in a six-year-old boy suffering from recurrent acute liver failure.

The transplant was made possible after the child’s father donated the left lobe of his liver. The procedure was completed successfully, with the child showing good early recovery, the liver graft functioning well and no complications observed.

According to KFSHRC in a statement, the patient had Wolcott-Rallison syndrome, a rare inherited disorder that causes early-onset diabetes and recurrent episodes of acute liver failure, placing him at repeated, life-threatening risk.

The transplant addressed the disease’s most serious complication, offering the boy a chance at a more stable life while easing the medical and emotional burden on his family. He will continue to receive follow-up care for his underlying genetic condition and diabetes.

A single-port robotic system allows surgeons to introduce precision surgical instruments and a high-definition 3D camera through one small incision, unlike conventional multi-port robotic surgery, which requires several access points.

Working through this single port, surgeons carried out the most delicate stages of the transplant inside the child’s body, where the confined surgical field required extremely precise handling of blood vessels and bile ducts. The approach helped reduce surgical impact, ease pain, and shorten recovery time and hospital stay.

This milestone builds on a pioneering path KFSHRC began in 2023 with the world’s first fully robotic liver transplant, which has since grown into an integrated programme with 165 cases performed to date, supported by experience from more than 1,700 robotic living-donor liver resections.

This accumulated expertise reflects the hospital’s ability to turn landmark achievements into advanced clinical programmes that change the course of entire families’ lives, expanding the use of robotics in highly complex transplant surgery and strengthening Saudi Arabia’s position in medical innovation and healthcare excellence.

Ranked first in the Middle East and Africa and 12th globally among the world’s top 250 academic medical centres for 2026, KFSHRC was also recognised as the most valuable healthcare brand in Saudi Arabia and the Middle East for 2026 by Brand Finance. It was also listed by Newsweek among the World’s Best Hospitals, World’s Best Smart Hospitals and World’s Best Specialised Hospitals for 2026.

— BERNAMA

Healthcare Partners Protocol & Solutions Committee (HPPSC) Launches and Spearheading Key Initiatives to Enhance Communication, Operational Efficiency and Customer Experience in Malaysia’s Healthcare Ecosystem

Mark O’Dell, LIAM CEO

Joint Press Statement by MMA, APHM, LIAM, MTA, AND PIAM 

KUALA LUMPUR, June 19 (Bernama) — The Healthcare Partners Protocol & Solutions Committee (HPPSC) implemented two initiatives* and continues to drive a series of strategic initiatives aimed at enhancing a seamless communication and improving operational efficiency among doctors, hospitals, insurers and takaful operators (ITOs), enhancing the overall customer experience across the healthcare ecosystem.

Key Initiatives by HPPSC 

1. Improving Communication Between Medical Practitioners and ITOs
To facilitate more efficient and timely medical and health insurance and takaful (MHIT) claims for patients, the HPPSC has recommended for the establishment of a dedicated “doctor-to-doctor” hotline by ITOs. In response to this recommendation, the hotline was implemented and has been operational since 30 April 2026 to support and address claims enquiries, as well as enable direct discussions between medical practitioners and the medical advisory team at ITOs. Such discussions are often necessary to understand case-specific matters such as treatment pathways and the use of new technologies or drugs.
*https://www.liam.org.my/news/press_details.aspx?ps=11166&ct=3,
Healthcare Budget Planner
 

This initiative is expected to strengthen communication, improve mutual understanding and support better coordination between medical practitioners and ITOs. This is intended to result in faster resolution of claims queries that will lead to better patient care and treatment decisions.

2. Enhancing Transparency in Panelling and Review Processes for Cashless Facility
The HPPSC has established a transparent and streamlined governance framework to support the panelling review and appeal processes relating to healthcare providers participating in cashless facility arrangements under MHIT products. The framework establishes a structured panelling review and appeal processes with clear guiding principles to promote fair and impartial assessment, continuous engagement, consistent decision-making and ongoing oversight. This initiative aims to strengthen confidence while improving governance and stakeholder engagement to promote prudent healthcare spending, strengthen governance, and enhance the overall integrity and sustainability of the MHIT ecosystem.  

3. Improving MHIT Claims Management Operational Efficiency
As part of ongoing efforts to improve operational efficiency and consistency in claims management, the HPPSC is undertaking several initiatives relating to clinical protocols and policy coverage.

These initiatives include: 

(a) Claims Management Processes
Developing processes to guide ITOs in managing clinical queries involving treatments recommended by medical practitioners that may not be directly aligned with or covered under existing Clinical Practice Guidelines (CPGs) issued by MOH through Malaysian Health Technology Assessment Section (MaHTAS). 

(b) Best Practices for Emerging Medical Technologies and Treatments
Developing best practices recommendations to support ITOs in assessing and determining MHIT coverage for new procedures, diagnostics, treatments and medicines, including emerging medical technologies such as robotic surgery, genetic testing and new cancer therapies. 

(c) Cancer Drug List Alignment and Awareness
Endorsing a cancer drug list developed in alignment with the MOH’s prescribed formulary prior to publication by MOH (NPRA). This initiative is intended to ensure healthcare providers remain updated on the MOH’s current prescribed cancer drug formulary.

The above initiatives will also include:
• Collaboration with the MOH, hospitals, treating specialists and relevant medical associations to facilitate alignment and resolution; and
• The implementation of mechanisms to disseminate outcomes, protocols and solutions arising from such engagements to all ITOs to promote greater consistency in application. 

4. Streamlining the Guarantee Letter (GL) Issuance Process
HPPSC will work towards simplifying and improving the Guarantee Letter (GL) issuance process to support timely issuance and more effective communication between ITOs, TPAs, medical practitioners and hospitals. 

This initiative aims to reduce administrative inefficiencies, improve coordination among stakeholders and enhance patients’ overall experience during hospital admissions and treatment. 

The initiatives undertaken by HPPSC reflect the Committee’s ongoing commitment to fostering greater collaboration, transparency and operational efficiency across the healthcare ecosystem. 

Commenting on the progress and significance of these initiatives, the Co-Chairs of HPPSC shared the following:

Chief Executive Officer of LIAM, Mark O’Dell said “HPPSC reflects what can be achieved when all stakeholders across the healthcare ecosystem come together with a shared purpose. These initiatives are designed to strengthen communication, improve operational efficiency and enhance transparency, ultimately benefiting patients and policyholders. As healthcare needs continue to evolve, it is important that insurers, takaful operators, healthcare providers and regulators work collaboratively to develop practical and sustainable solutions that support timely access to care while ensuring the long-term affordability and sustainability of medical and health insurance and takaful coverage for Malaysians.”

Dr Gunalan Palari @ Arumugam Palari of Malaysia Medical Association added “Effective patient care depends on strong collaboration and mutual understanding among all parties involved in the healthcare journey. Through HPPSC, we have established a constructive platform that enables healthcare providers and healthcare financiers to address operational challenges, improve communication and develop solutions that support better clinical and patient outcomes. The implementation of initiatives such as the “doctor-to-doctor” hotline demonstrates our collective commitment to ensuring patients receive timely, appropriate and coordinated care.”

Commitment to Continued Collaboration
The Malaysian Medical Association (MMA), Association of Private Hospitals of Malaysia (APHM), Life Insurance Association (LIAM), Malaysian Takaful Association (MTA), and General Insurance Association of Malaysia (PIAM) reaffirm their commitment to constructive collaboration and continuous engagement in strengthening the sustainability, transparency and efficiency of Malaysia’s healthcare financing ecosystem. 

The HPPSC will continue to serve as a platform for practical problem-solving, constructive engagement and industry collaboration in support of better healthcare access and patient outcomes for all Malaysians. 

The Committee brings together representatives from healthcare providers and healthcare financing stakeholders, including MMA, APHM, insurers and takaful operators (ITOs), as well as third-party administrators (TPAs), with observers from the Ministry of Health (MOH) and Bank Negara Malaysia (BNM). It is co-chaired by MMA and LIAM, with the support of PIAM and MTA, reflecting a shared commitment to collaborative solutions.

Issued jointly by:
• Malaysian Medical Association (MMA)
• Association of Private Hospitals Malaysia (APHM)
• Life Insurance Association of Malaysia (LIAM)
• Malaysian Takaful Association (MTA)
• Persatuan Insurans Am Malaysia (PIAM) 

SOURCE: Life Insurance Association of Malaysia (LIAM)

FOR MORE INFORMATION, PLEASE CONTACT:

MMA:
Name: Mr Darren Atkinson
Press Officer
Malaysian Medical Association
Level 4, MMA House
124 Jalan Pahang
53000 Kuala Lumpur
Tel: 03 4041 1375 / +60 12-295 5042
Fax: 03 4041 8187
Email: secretary@mma.org.my
Website: mma.org.my

APHM:
Name: Muhammad Badri Hussin
CEO
Associations of Private Hospitals of Malaysia
A-17-01 Menara UOA Bangsar
5, Jalan Bangsar Utama 1
59000 Kuala Lumpur
Tel : 603 22841701
Email : badri@aphm.org.my / aphm@aphm.org.my
Website : https://aphm.org.my

LIAM:
Puan Norizan Hassan
Head of Corporate Communications
Life Insurance Association of Malaysia
Level 6, AICB Building
No. 10, Jalan Dato’ Onn
50480 Kuala Lumpur
Tel: 603-2691 6168 / 6628 / 8068
Email: liaminfo@liam.org.my
Website: http://www.liam.org.my
Facebook: LIAM – Life Insurance Association of Malaysia
Instagram: @liamalaysia 

MTA:
Name: Puan Siti Nor Kamariah Ishak
Head, Corporate Communications
18th Floor, Main Block
Menara Takaful Malaysia
Jalan Sultan Sulaiman
50000 Kuala Lumpur
Tel: 018-355 1427
Fax: +603-2031 8170
Email: mtasecretariat@malaysiantakaful.com.my

PIAM:
Name: Ms. Susanna G. Simon
Manager, Communications
Persatuan Insurans Am Malaysia (PIAM)
Wisma PIAM
150, Jalan Tun Sambanthan
50470 Kuala Lumpur, Wilayah Persekutuan
Tel: 03-2274 7399
Fax: 03-2274 5910
Email: susanna.simon@piam.org.my
Website: http://www.piam.org.my

–BERNAMA

EAACI CHAMPIONS VISION ZERO TO REDUCE ALLERGY, ASTHMA BURDEN

KUALA LUMPUR, June 12 (Bernama) — The European Academy of Allergy and Clinical Immunology (EAACI) is calling for a new global health ambition through Vision Zero, a future free from the burden of allergy and asthma.

As allergic diseases continue to affect hundreds of millions of people worldwide and place growing pressure on healthcare systems, this vision will serve as the central theme of the four-day EAACI Annual Congress 2026 in Istanbul, Türkiye, beginning June 12.

The congress will bring together thousands of clinicians, researchers and healthcare professionals to discuss the latest scientific advances and the future of allergy and asthma care, according to EAACI in a statement.

“Vision Zero reflects our determination to move beyond disease management and towards disease prevention and burden reduction. Through collaboration across research, clinical practice and public health, we can work towards a future where allergy and asthma no longer limit the lives of millions,” said EAACI President, María Torres.

EAACI believes scientific innovation, prevention strategies and coordinated policy action can significantly reduce the impact of allergic and respiratory diseases on individuals, families and societies rather than accepting them as an inevitable and growing public health challenge.

The congress will showcase emerging research and clinical developments in immunotherapy, environmental and genetic factors, digital health technologies, precision medicine and preventive approaches. Discussions will also address health equity and the need to ensure that advances in allergy and asthma care are accessible to patients worldwide.

Allergic diseases are among the most common chronic conditions globally, and their burden extends beyond healthcare to affect education, productivity, quality of life and mental wellbeing.

Against this backdrop, EAACI’s Vision Zero initiative seeks to encourage long-term thinking about what is possible when scientific discovery is matched by effective implementation and policy support. The congress is expected to bring together experts worldwide to accelerate progress towards substantially reducing the burden of allergy and asthma.

— BERNAMA

TIME FOR ASSURERS TO ACT FOR THE BENEFIT OF POLICY OWNERS

KUALA LUMPUR, March 24 (Bernama) —

Introduction

Despite calls to engage insurers privately and not moot their points through media, APHM continues airing its concerns publicly. The general public couldn’t care less about this issue. These are private matters between APHM and Insurers. As mentioned in the same article, the relationship between private hospitals and insurers is best described as symbiotic. APHM must find solutions that flourish this relationship rather than be parasitic.  

APHM proposes the formation of a joint working committee between the association and Assurers to review billing structures and ensure fair pricing of healthcare services. It is a good start, but it needs to focus its energy on the core matter, the burdening hospital charges that cause assurers to increase their prices. The billing structure and so-called fair pricing don’t solve the current problems. It is more of an academic exercise. 

APHM’s public statements call for assurers to keep cashless medical products while using patient care as a smoke screen. It is a ruse to maintain its top and bottom line, and its sincerity can be seen when it issued a statement rejecting Assurer’s proposal for private hospitals to freeze costs for three years and also for the Health Ministry to regulate the pricing of pharmaceuticals or medication during the period assurers facing premium pricing caps. 
Public Education
Since APHM is only interested in making public statements to try to arouse policyholders’ sentiments to protect their cash flow and profit margins, it is time for assurers to take steps to protect policy owners’ interests. The public is concerned about rising health premiums. They don’t understand the reasons behind it.   

Therefore, assurers need to expand their role in public education on how assurers develop their product prices. Most of the cost goes toward paying claims, distribution costs, and maintaining statutory reserves. Assurers must demonstrate how much premium is allocated to companies as their pretax profits for every ringgit of premium received. 

Public education goes a long way and will make the public understand the financial burden caused by APHM members.

Cheaper, Scalable & Customized Direct Products
Policy owners deserve access to cheaper health assurance products. Insurers can consider two critical modifiable parameters: direct distribution without going through agents and selling the product on a reimbursement basis. Distribution through agents is costly. Technology today allows companies to educate customers on product features with ease. Product distribution has greater depth today.  

Assurers can develop tier products that cover the treatment of medical risks for specific age groups. The young have a lesser risk of admission due to chronic illnesses. The sum cover can be lowered since the cost of treatment for acute illnesses and injuries is low. Employees can buy a small sum for the employed category to cover health top-up products, where the primary claim should be against the employer’s paid assurance. The top-up is used only when the primary product limits are exhausted. 

The second strategy would be reintroducing reimbursement-based products. It has dual key advantages. First, the policy owners are responsible for controlling hospital bill expenses. Coupled with BNM directives of Co-payment, policy owners would question their hospital charges. Introducing Co-pay reimbursement products is within the assurer’s rights. We cannot blame APHMs for making public statements and calling for assurers to keep cashless medical products as they know it significantly impacts their earnings. 

The third strategy is for assurers to revisit and expand the strategy they introduced in early 2000, where they formed a consortium that markets national health assurance products instead of individual company products. An industry-wide product allows the consolidation of claim data to determine the true industry burning costs. More importantly, consolidating policy owners’ data enables the industry to spread costs and introduce cheaper products. Individual assurance companies only need to focus on distribution and customer service. The focus would be on customer service. This approach would be the seed of the National Health Assurance under the assurance industry-driven National Healthcare Financing System. 

Under this approach, the competition among the assurance companies is no longer on pricing. The law of large numbers dictates and has an impact on price. However, if private hospitals continue to have the unchecked freedom to determine the charges, the proposed measures will only temporarily reprieve policy owners.   

Conclusion
In the best interest of policy owners & to protect them against increasing premiums, re-introducing reimbursement health products would be the best approach. Policy owners themselves must take the role of questioning hospital charges, which directly impacts health assurance premiums. 

Assurers must develop products that limit the benefit payment according to age, gender, pre-existing conditions and risk exposure. A young person who enjoys employer insurance coverage does not need an RM1000,000 sum of cover. Having high annual and lifetime limits promotes “medical inflation”. 

Assurers must get their act together as an industry, focus on their policy owners, ignore APHM public statements and develop a structured public education program explaining how assurers’ price their products.

21-3-2025  

Dr Mohamed Rafick Khan 
Reassurer and Assurance Industry Consultant

Dr. Mohamed Rafick is a trained physician with 12 years of experience in military medical services and over 22 years of experience in the assurance industry. He retired as the CEO of a multinational reinsurance company in 2019. Currently, he remains active as an independent international assurance industry consultant.

SOURCE: Dr Mohamed Rafick Khan 
Reassurer and Assurance Industry Consultant

FOR MORE INFORMATION, PLEASE CONTACT:
Name: Dr Rafick 
Tel: 012 2218956
Email: drrafick@gmail.com

–BERNAMA